United Therapeutics

MD - Silver SpringBiotechnology3 H-1B visas (FY2023)

Focus: United Therapeutics is a specialty biotech focused on small molecules and biologics across cardiovascular, oncology, respiratory, nephrology, and infectious diseases. The company is heavily dependent on its pulmonary hypertension franchise, which generates 97% of revenue from TYVASO DPI.

Cardiovascular Oncology Respiratory Nephrology

Profile data last refreshed 16h ago · AI intelligence enriched 1w ago

Open Jobs

About United Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow United Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

2 in 5yr

REMODULIN

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

TYVASO DPI

Pulmonary hypertension

$437M Part D

Peak15.5yr

Core revenue driver (97% of sales); vasodilatator and platelet aggregation inhibitor with extended protection until 2042.

Help build intelligence for United Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)

Pulmonary Arterial Hypertension

N/A

Clinical Trials (1)

NCT01043627Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)

N/A

Adiposity and Iron Requirements in Pregnancy

Iron Deficiency Anemia of Pregnancy

N/A

Clinical Trials (1)

NCT06425796Adiposity and Iron Requirements in Pregnancy

N/A

Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

Pulmonary Arterial Hypertension

N/A

Clinical Trials (1)

NCT01799473Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

N/A

PET/MRI

Pulmonary Arterial Hypertension

N/A

Clinical Trials (1)

NCT04090866Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study

N/A

Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching

Pulmonary Arterial Hypertension

N/A

Clinical Trials (1)

NCT01494896Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching

N/A

SPRINT Peripheral Nerve Stimulation

Post-Amputation Pain

N/A

Clinical Trials (1)

NCT01996254Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System

N/A

Model 10642 Implantable Intravascular Catheter

Pulmonary Arterial Hypertension

N/A

Clinical Trials (1)

NCT01321073DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study

N/A

Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodul

Pulmonary Arterial Hypertension

N/A

Clinical Trials (1)

NCT02074449Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)

N/A

ChemoFX Assay

Breast Cancer

N/A

Clinical Trials (1)

NCT01007890Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer

N/A

The Myelin Disorders Biorepository Project

Leukodystrophy

N/A

Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH

Pulmonary Arterial Hypertension

N/A

Clinical Trials (1)

NCT02318186Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)

N/A

Remunity Pump for Remodulin

Pulmonary Arterial Hypertension

N/A

Clinical Trials (1)

NCT05060315Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin

N/A

Prospective study assessments

Pulmonary Hypertension Due to Lung Diseases and Hypoxia

N/A

Clinical Trials (1)

NCT06388421DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

N/A

ACTIVE peripheral nerve stimulation with a percutaneously inserted lead and wearable stimulator

Rotator Cuff Repair

N/A

Clinical Trials (1)

NCT03481725Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study

N/A

SPRINT Peripheral Nerve Stimulation

Low Back Pain

N/A

Clinical Trials (1)

NCT04246281The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain

N/A

Remodulin

Congenital Heart Disease

N/A

ECG-based AI Device - Results Returned to Investigator

Pulmonary Hypertension

N/A

Clinical Trials (1)

NCT06911632Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

N/A

Treprostinil

Portopulmonary Hypertension

N/A

SPRINT Peripheral Nerve Stimulation

Postoperative Pain

N/A

Clinical Trials (1)

NCT04341948Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System

N/A

Right heart catheterization

Interstitial Lung Disease